MEDIPRIX

About MEDIPRIX

MEDIPRIX operates as a health brand and network for independent pharmacies, aiming to support their development and profitability in a shifting market. Founded in 2016 by pharmacists Bertrand Pagès and Jérôme Escojido, the company was born from their vision to create a modern yet ethical alternative to both stagnant traditional pharmacies and impersonal, discount-focused models. Both founders graduated from the Faculty of Pharmacy in Montpellier and leveraged their experience in opening several pharmacies to establish the network.

The company's core business revolves around a group purchasing organization that unites independent pharmacies under the MEDIPRIX banner. As of early 2025, the network includes over 250 pharmacies, collectively generating more than one billion euros in revenue under the brand. This model allows member pharmacies to improve profitability through collective bargaining with laboratories, access to marketing budgets, and the development of high-margin product corners. The client base consists of independent pharmacy owners, who are selected based on their entrepreneurial and dynamic profiles to ensure a cohesive and engaged network. Revenue is generated through membership fees and partnerships with pharmaceutical laboratories.

MEDIPRIX provides its members with a suite of digital tools and support services. This includes proprietary software that uses data and AI to optimize operations, a digital platform for appointment booking and prescription services, and a click-and-collect feature via the MEDIPRIX app. The company also offers a range of exclusive in-house brands, such as Médicinal, Mediexpert, Medisens, and Viva, focusing on natural products and herbalism. Beyond digital solutions, the firm provides training, diverse support services, and assistance with investment projects. A significant milestone was the securing of a €16 million Series B funding round in July 2023 from NextStage AM to fuel further growth in France and Europe.